EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Identification of Hammerhead-variant ribozyme sequences in SARS-CoV-2

Getong Liu, Hengyi Jiang, Dongrong Chen, Alastair I H Murchie iD

Nucleic Acids Research · 2024

DOI: 10.1093/nar/gkae037 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Nucleic Acids Research, 2024. Verfasst von Getong Liu und 3 weiteren Autor:innen. Beteiligte Einrichtung: Shanghai Pudong Hospital, Fudan University Pudong Medical Center and Institutes of Biomedical Sciences, Shanghai Medical College, Key Laboratory of M…. Hauptthemen laut MEDLINE: RNA, Catalytic, SARS-CoV-2. Die Arbeit wurde bisher 2-mal zitiert (Crossref) und nennt 68 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: National Natural Science Foundation.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

The SARS-CoV-2 RNA virus and variants, responsible for the COVID-19 pandemic has become endemic, raised a need for further understanding of the viral genome and biology. Despite vast research on SARS-CoV-2, no ribozymes have been found in the virus genome. Here we report the identification of 39 Hammerhead-variant ribozyme sequences (CoV-HHRz) in SARS-CoV-2. These sequences are highly conserved within SARS-CoV-2 variants but show large diversity among other coronaviruses. In vitro CoV-HHRz sequences possess the characteristics of typical ribozymes; cleavage is pH and ion dependent, although their activity is relatively low and Mn2+ is required for cleavage. The cleavage sites of four CoV-HHRz coincide with the breakpoint of expressed subgenomic RNA (sgRNAs) in SARS-CoV-2 transcriptome data suggesting in vivo activity. The CoV-HHRz are involved in processing sgRNAs for ORF7b, ORF 10 and ORF1ab nsp13 which are essential for viral packaging and life cycle.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

RNA, CatalyticSARS-CoV-2HumansCOVID-19PandemicsRNA, ViralSubgenomic RNA

Substanzen

RNA, CatalyticRNA, ViralSubgenomic RNAhammerhead ribozyme

Autor:innen und Institutionen

  • Shanghai Pudong Hospital, Fudan University Pudong Medical Center and Institutes of Biomedical Sciences, Shanghai Medical College, Key Laboratory of Medical Epigenetics and Metabolism, Fudan University, Shanghai 200032,…
  • Key Laboratory of Metabolism and Molecular Medicine, Ministry of Education, School of Basic Medical Sciences, Fudan University, Shanghai 200032, China.

ORCID-Profile: Alastair I H Murchie

Förderung

  • National Natural Science Foundation

Zitieren

APA

Liu, G., Jiang, H., Chen, D., & Murchie, A. I. H. (2024). Identification of Hammerhead-variant ribozyme sequences in SARS-CoV-2. Nucleic Acids Research. https://doi.org/10.1093/nar/gkae037

Vancouver

Liu G, Jiang H, Chen D, Murchie AIH. Identification of Hammerhead-variant ribozyme sequences in SARS-CoV-2. Nucleic Acids Research. 2024. doi:10.1093/nar/gkae037

BibTeX
@article{Liu2024,
  author = {Liu, Getong and Jiang, Hengyi and Chen, Dongrong and Murchie, Alastair I H},
  title = {Identification of Hammerhead-variant ribozyme sequences in SARS-CoV-2},
  journal = {Nucleic Acids Research},
  year = {2024},
  doi = {10.1093/nar/gkae037}
}
Kostenlos starten →